Loading clinical trials...
Loading clinical trials...
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Induction and Maintenance Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Subjects With Eosinophilic Gastroenteritis
Conditions
Interventions
CC-93538
Placebo
Locations
25
Japan
Local Institution - 024
Gifu, Gifu, Japan
Local Institution - 022
Himeji-shi, Hyōgo, Japan
Local Institution - 009
Nishinomiya, Hyōgo, Japan
Local Institution - 0025
Tsu, Mie-ken, Japan
Local Institution - 025
Tsu, Mie-ken, Japan
Local Institution - 023
Sendai, Miyagi, Japan
Start Date
March 4, 2022
Primary Completion Date
July 2, 2024
Completion Date
August 22, 2025
Last Updated
October 21, 2025
NCT05199532
NCT05439772
NCT05251909
NCT03664960
NCT03496571
NCT02897271
Lead Sponsor
Celgene
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions